Active Wound Care Market Size

Active Wound Care Market Analysis

The active wound care market is estimated to be worth USD 2.89 billion in the current year, and it is expected to reach USD 3.78 billion during the forecast period. The market is expected to register a CAGR of 4.64% during the forecast period.

The COVID-19 pandemic placed a significant strain on healthcare systems worldwide as resources were diverted to manage COVID-19 cases, resulting in disruptions in routine healthcare services, including wound care. Non-essential wound care procedures were delayed or postponed, which impacted the adoption and utilization of active wound care products. For instance, according to a study published by the World Journal of Emergency Service in September 2021, during the pandemic, there was more than 50% reduction in traffic accidents in 12 countries, 25% to 49% in 14 countries, and less than 25% in six countries compared to pre-pandemic years. This was due to the sharp decline in traffic volume brought on by the COVID-19 pandemic. Thus, due to the reduced traffic accidents and injuries, the demand for active wound care products declined, which impacted the market growth over the study period. However, the pandemic also led to a surge in hospitalizations and an increase in surgical wounds and wounds that were prone to the development of pressure ulcers. For instance, according to an article published by the Elsevier Journal in August 2022, critical care patients were at higher risk of developing pressure ulcers during the pandemic owing to their immobility, reliance on pressure relief devices, and regular position changes. Therefore, a decrease in the number of road accidents and the postponement of hospitalizations severely impacted the active wound care market's growth during the initial phase of the pandemic. However, due to the high prevalence and risk of wounds in COVID-19 patients and the reopening of all services, the market picked up and is expected to witness significant growth during the forecast period.

The factors driving the market's growth include the high prevalence of acute and chronic wounds, the rising number of innovative product launches, and the increasing number of surgeries.

The prevalence of chronic diseases like diabetes, obesity, and cardiovascular conditions often lead to complications such as diabetic foot ulcers and arterial ulcers, which is driving market growth. For instance, according to an article published by the American Diabetes Association in December 2022, diabetes often leads to diabetic foot ulcers (DFU), mainly with longstanding and poorly managed diabetes. As per the same source, out of the estimated 537 million people with diabetes globally, around 19% to 34% will develop a DFU in their lifetime. The abovementioned source also states that the major reasons for the high morbidity of DFU are the aging population, obesity, smoking habits, and cardiovascular diseases. Active wound care products such as growth factors and biomaterials are used for DFUs to stimulate the wound healing process. Thus, with more people being affected by such chronic diseases, the number of chronic wounds requiring advanced wound care solutions is projected to increase during the forecast period.

The rising number of innovative product launches related to active wound care, specifically in the areas of biomaterials, skin substitutes, and growth factors, is expected to drive the growth of the active wound care market during the forecast period. For instance, in May 2022, the Technical University of Munich (TUM) in Germany developed a new kind of film dressing using mucin biomolecules for the protection of wounds. This dressing is also incorporated with active pharmaceutical ingredients to accelerate wound healing, expel bacteria, inhibit inflammation, and finally decompose on the skin by itself. Similarly, in June 2022, Collagen Matrix Inc. received the US Food and Drug Administration (US-FDA) approval for a new fibrillar collagen wound dressing. The Collagen Matrix Fibrillar Collagen Wound Dressing is an absorbent microfibrillar matrix used to treat wounds that moderately exude fluid and control mild bleeding. Therefore, the rising number of biomaterial-based wound care products by prominent players is projected to drive market growth during the forecast period.

Procedures such as breast reconstruction, facial reconstruction, and body contouring surgeries are becoming increasingly popular. They often involve significant tissue manipulation and reconstruction. These procedures create a need for advanced wound care products to promote healing and optimize cosmetic outcomes, thereby driving the active wound care market's growth. For instance, according to the Aesthetic Plastic Surgery, National Databank STATISTICS 2020-2021 released by the Aesthetic Society in April 2022, the total number of plastic surgical procedures increased by 54% and non-surgical procedures by 44% in the United States in 2021 compared to the previous year. As per the same source, there were 365,000 breast augmentations and 167,395 mastopexy procedures performed in the United States in 2021. After breast augmentation and mastopexy, the incision sites are considered surgical wounds, and appropriate wound care is essential to minimize complications and promote proper healing. Therefore, the increasing number of plastic surgeries is expected to drive the growth of the active wound care market.

Hence, factors such as the increasing prevalence of acute and chronic wounds, the rising number of innovative product launches, and the increasing number of surgeries are projected to drive market growth during the forecast period.